Related Experiment Videos

2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine

Insights

Researchers identified 2-fluoro-ATP as a novel metabolite of the anticancer drug arabinosyl 2-fluoroadenine in murine cells. This finding advances understanding of drug metabolism and potential therapeutic efficacy.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Cancer Research

Background:

  • Murine P388 cells are a common model for studying anticancer drug efficacy.
  • Arabinosyl 2-fluoroadenine is an anticancer drug known to form phosphorylated metabolites.
  • Understanding drug metabolism is crucial for optimizing cancer therapy.

Purpose of the Study:

  • To identify and characterize novel phosphorylated metabolites of arabinosyl 2-fluoroadenine.
  • To elucidate the metabolic pathway of arabinosyl 2-fluoroadenine in cancer cells.
  • To investigate the formation of 2-fluoro-ATP from arabinosyl 2-fluoroadenine.

Main Methods:

  • In vitro incubation of murine P388 cells with arabinosyl 2-fluoroadenine.
  • High-performance liquid chromatography (HPLC) for metabolite separation and identification.
  • Enzymatic dephosphorylation and chemical oxidation (NaIO4) for structural confirmation.

Main Results:

  • The major phosphorylated metabolite was identified as arabinosyl 2-fluoroadenine 5'-triphosphate (F-araATP).
  • A novel metabolite, 2-fluoro-ATP, was identified, accumulating at 10% of F-araATP levels.
  • 2-fluoro-ATP was confirmed by coelution on HPLC, dephosphorylation to 2-fluoroadenosine, and sensitivity to NaIO4 oxidation.
  • Cellular studies indicated 2-fluoroadenine as the precursor to 2-fluoro-ATP.

Conclusions:

  • 2-fluoro-ATP is a significant, previously unidentified metabolite of arabinosyl 2-fluoroadenine.
  • The metabolic pathway involves 2-fluoroadenine as an intermediate in 2-fluoro-ATP formation.
  • This research provides insights into the metabolic fate of arabinosyl 2-fluoroadenine, relevant for drug development.

Related Concept Videos